Syon Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,722
Closed -$383K 767
2025
Q1
$383K Buy
25,722
+8,972
+54% +$138K 0.03% 364
2024
Q4
$250K Buy
16,750
+4,515
+37% +$73.6K 0.02% 458
2024
Q3
$234K Sell
12,235
-623
-5% -$12.9K 0.02% 412
2024
Q2
$266K Buy
12,858
+57
+0.4% +$1.13K 0.02% 376
2024
Q1
$241K Buy
12,801
+173
+1% +$2.97K 0.02% 400
2023
Q4
$182K Buy
+12,628
New +$172K 0.02% 435

Other funds holding OGN

Syon Capital's OGN Position: Q2 2025 in Review

Syon Capital sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 25,722 shares — an estimated $383K sold.

Syon Capital first reported a position in OGN in Q4 2023 and held it in 6 quarters. The position peaked at $383K in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Syon Capital reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Syon Capital sold 25,722 Organon & Co shares in Q2 2025, an estimated $383K.
  • Syon Capital first reported a position in Organon & Co in Q4 2023 and held it in 6 quarters.
  • Syon Capital's Organon & Co position peaked at $383K in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Syon Capital's 13F filing for Q2 2025, filed 14 Aug 2025.